Linc AB
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and o… Read more
Linc AB (LINC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.003x
Based on the latest financial reports, Linc AB (LINC) has a cash flow conversion efficiency ratio of 0.003x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr13.90 Million) by net assets (Skr4.43 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Linc AB - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Linc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Linc AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Linc AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai National Center of Testing and Inspection for Electric Cable and Wire Co. Ltd.
SHE:301289
|
-0.003x |
|
TruBridge Inc.
NASDAQ:TBRG
|
0.075x |
|
The Keg Royalties Income Fund
TO:KEG-UN
|
0.073x |
|
Kreditbanken A/S
CO:KRE
|
0.001x |
|
PowerCell Sweden AB (publ)
PINK:PCELF
|
0.016x |
|
Hes Technology Group
SHE:002963
|
0.053x |
|
PROTALIX BIOTHERAP.DL-01
F:PBDA
|
N/A |
|
Diamyd Medical AB (publ)
ST:DMYD-B
|
-0.189x |
Annual Cash Flow Conversion Efficiency for Linc AB (2018–2025)
The table below shows the annual cash flow conversion efficiency of Linc AB from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr4.43 Billion | Skr4.25 Million | 0.001x | -84.37% |
| 2024-12-31 | Skr4.83 Billion | Skr29.68 Million | 0.006x | +126.91% |
| 2023-12-31 | Skr3.53 Billion | Skr-80.57 Million | -0.023x | +70.88% |
| 2022-12-31 | Skr2.91 Billion | Skr-228.15 Million | -0.078x | +19.49% |
| 2021-12-31 | Skr3.63 Billion | Skr-353.84 Million | -0.097x | -1560.96% |
| 2020-12-31 | Skr2.49 Billion | Skr-14.63 Million | -0.006x | -929.67% |
| 2019-12-31 | Skr1.66 Billion | Skr1.17 Million | 0.001x | +103.83% |
| 2018-12-31 | Skr1.06 Billion | Skr-19.65 Million | -0.018x | -- |